626 related articles for article (PubMed ID: 25895136)
1. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
2. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
Her J; Jeong YY; Chung IK
FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
[TBL] [Abstract][Full Text] [Related]
3. RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha.
van Hagen M; Overmeer RM; Abolvardi SS; Vertegaal AC
Nucleic Acids Res; 2010 Apr; 38(6):1922-31. PubMed ID: 20026589
[TBL] [Abstract][Full Text] [Related]
4. RNF4-mediated SUMO-targeted ubiquitination relieves PARIS/ZNF746-mediated transcriptional repression.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2020 May; 526(1):110-116. PubMed ID: 32197837
[TBL] [Abstract][Full Text] [Related]
5. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
6. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
7. An arginine-rich motif of ring finger protein 4 (RNF4) oversees the recruitment and degradation of the phosphorylated and SUMOylated Krüppel-associated box domain-associated protein 1 (KAP1)/TRIM28 protein during genotoxic stress.
Kuo CY; Li X; Kong XQ; Luo C; Chang CC; Chung Y; Shih HM; Li KK; Ann DK
J Biol Chem; 2014 Jul; 289(30):20757-72. PubMed ID: 24907272
[TBL] [Abstract][Full Text] [Related]
8. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
Han MM; Hirakawa M; Yamauchi M; Matsuda N
Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
Gibbs-Seymour I; Oka Y; Rajendra E; Weinert BT; Passmore LA; Patel KJ; Olsen JV; Choudhary C; Bekker-Jensen S; Mailand N
Mol Cell; 2015 Jan; 57(1):150-64. PubMed ID: 25557546
[TBL] [Abstract][Full Text] [Related]
10. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
Ahner A; Gong X; Frizzell RA
FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
[TBL] [Abstract][Full Text] [Related]
12. PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
Rabellino A; Melegari M; Tompkins VS; Chen W; Van Ness BG; Teruya-Feldstein J; Conacci-Sorrell M; Janz S; Scaglioni PP
Cell Rep; 2016 Jun; 15(10):2266-2278. PubMed ID: 27239040
[TBL] [Abstract][Full Text] [Related]
13. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.
Belaguli NS; Zhang M; Brunicardi FC; Berger DH
PLoS One; 2012; 7(10):e48019. PubMed ID: 23118920
[TBL] [Abstract][Full Text] [Related]
14. A CK2-RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR.
Bilodeau S; Caron V; Gagnon J; Kuftedjian A; Tremblay A
J Mol Cell Biol; 2017 Jun; 9(3):195-208. PubMed ID: 28201649
[TBL] [Abstract][Full Text] [Related]
15. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
[TBL] [Abstract][Full Text] [Related]
16. Different SUMO paralogues determine the fate of wild-type and mutant CFTRs: biogenesis versus degradation.
Gong X; Liao Y; Ahner A; Larsen MB; Wang X; Bertrand CA; Frizzell RA
Mol Biol Cell; 2019 Jan; 30(1):4-16. PubMed ID: 30403549
[TBL] [Abstract][Full Text] [Related]
17. RNF4 promotes tumorigenesis, therapy resistance of cholangiocarcinoma and affects cell cycle by regulating the ubiquitination degradation of p27kip1 in the nucleus.
Huang J; Yang W; Jiang K; Liu Y; Tan X; Luo J
Exp Cell Res; 2022 Oct; 419(1):113295. PubMed ID: 35926659
[TBL] [Abstract][Full Text] [Related]
18. SUMO wrestles down myc.
Dohmen RJ
Cell Cycle; 2015; 14(16):2551-2. PubMed ID: 26091089
[No Abstract] [Full Text] [Related]
19. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
20. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
